OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
68 hedge funds and large institutions have $36.2M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
-12
Holders Change %
-15%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
22
Reduced
17
Closed
18
Calls
$311K
Puts
$253K
Net Calls
+$58K
Net Calls Change
+$1M
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$724K |
| 2 |
Renaissance Technologies
New York
|
$1.19M |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
$292K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
$117K |
| 5 |
PP
PDT Partners
New York
|
$99K |
